Opinion of the Infectious Disease Specialist Referent for the Good Use of AnTiBiotics
NCT04603313 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4138
Last updated 2023-05-30
Summary
The increase in bacterial resistance and the overuse of antibiotics have led health authorities to propose incentives for the proper use of antibiotics. Among these measures, the introduction of referring physicians for antibiotic therapy and tele-advisory devices for infectious diseases have shown positive effects on antibiotic prescriptions in hospitals. Today, an increase is observed in the consumption of antibiotics linked to ambulatory prescriptions.
The objective of the project is to deploy tele-advice devices for general practitioners and to evaluate the effects on ambulatory antibiotic dispensing.
AIRBUS-ATB is a prospective, multi-center, population-based, interrupted time-series observational study with a control group with 12 points before and 24 points after the deployment of the intervention in voluntary territories.
Conditions
- Communicable Diseases
Interventions
- OTHER
-
tele-advice system
The intervention consists of setting up in each participating center an infectious disease tele-advice system available to general practitioners via a dedicated mobile telephone line.
Sponsors & Collaborators
-
University Hospital, Grenoble
lead OTHER
Principal Investigators
-
Patricia PAVESE, MD · CHU de Grenoble Alpes
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-15
- Primary Completion
- 2022-06-30
- Completion
- 2022-12-31
Countries
- France
Study Locations
More Related Trials
-
Molecular Detection of Antibiotic Resistance and H Pylori Eradication
NCT01168063 ·Status: COMPLETED ·Phase: NA
-
Israeli Judicious Antibiotic Prescription Study
NCT01187758 ·Status: COMPLETED ·Phase: NA
-
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT05332444 ·Status: RECRUITING ·Phase: PHASE4
-
Bacteriotherapy in the Treatment of COVID-19
NCT04368351 ·Status: UNKNOWN
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
NCT02961296 ·Status: UNKNOWN
-
Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health Care
NCT05090475 ·Status: COMPLETED ·Phase: NA
-
Community-based Helicobacter Pylori Eradication
NCT00155389 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection
NCT00210639 ·Status: COMPLETED
-
Comparative Efficacy of Single-dose Doxycycline Versus Standard 5- Day Amoxicillin Treatment
NCT03765931 ·Status: COMPLETED ·Phase: PHASE4
-
Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia
NCT00818610 ·Status: COMPLETED ·Phase: PHASE4
-
Antimicrobial Stewardship for Primary Care Pediatricians
NCT01806103 ·Status: COMPLETED ·Phase: NA
-
Non-routine Use of Antibiotics (Amoxi-light)
NCT03370003 ·Status: COMPLETED
-
Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment
NCT02988089 ·Status: UNKNOWN ·Phase: PHASE4
-
Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand
NCT07082465 ·Status: NOT_YET_RECRUITING
-
A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
NCT02689583 ·Status: UNKNOWN ·Phase: NA
-
Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity
NCT05475431 ·Status: COMPLETED
-
Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease
NCT00325897 ·Status: COMPLETED ·Phase: NA
-
Registry for the Management of Helicobacter Pylori Infection in Shandong Province
NCT07335406 ·Status: RECRUITING
-
A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis
NCT00649831 ·Status: COMPLETED ·Phase: PHASE3
-
Anti Infective Agents Impact in COVID-19 Pneumonia
NCT04453501 ·Status: COMPLETED
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
NCT03571230 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT03658746 ·Status: COMPLETED ·Phase: PHASE4
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
NCT03565484 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease
NCT06809413 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2